Sipuleucel-TDrugMonograph.docVIP

Sipuleucel-T (Provenge() National Drug Monograph March 2011 VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives The purpose of VA PBM Services drug monographs is to provide a comprehensive drug review for making formulary decisions. These documents will be updated when new clinical data warrant additional formulary discussion. Documents will be placed in the Archive section when the information is deemed to be no longer current. Executive Summary: Sipuleucel-T is the first autologous cellular immunotherapy designed to stimulate a T cell respons